Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amber L Beitelshees

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Circulation. Cardiovascular Genetics|November 17, 2010
Is ticagrelor the antiplatelet therapy panacea?Amber L Beitelshees
Lancet (London, England)|April 3, 2012
Personalised antiplatelet treatment: a RAPIDly moving targetAmber L Beitelshees
Heart Failure Reviews|March 21, 2008
Renin-angiotensin-aldosterone system (RAAS) pharmacogenomics: implications in heart failure managementAmber L Beitelshees, Issam Zineh
JAMA|September 22, 2011
Evolving research and stakeholder perspectives on pharmacogenomicsAmber L Beitelshees, David L Veenstra
Trends in Pharmacological Sciences|August 1, 2006
Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safetyAmber L Beitelshees, Howard L McLeod
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 2006
Clopidogrel pharmacogenetics: promising steps towards patient care?Amber L Beitelshees, Howard L McLeod
Interventional Cardiology|August 18, 2023
Familial Hyperlipidemia Caused by Apolipoprotein B Mutation in the Pediatric Amish Population: A Mini ReviewCorey Snyder, Amber L Beitelshees, Devyani Chowdhury
Pharmacogenomics and Personalized Medicine|April 22, 2015
Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomicsAmber L Beitelshees, Deepak Voora, Joshua P Lewis
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 27, 2007
Correlates of serum matrix metalloproteinase-8 (MMP-8) concentrations in nondiabetic subjects without cardiovascular diseaseChristina L Aquilante, Amber L Beitelshees, Issam Zineh
Pharmacogenetics and Genomics|July 19, 2006
Re: Meckley LM, Veenstra DL. Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis. Pharmacogenet Genom 2006; 16:139-147Tobias Gerhard, Amber L Beitelshees, Julie A Johnson
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Circulation. Cardiovascular Genetics|November 17, 2010
Is ticagrelor the antiplatelet therapy panacea?Amber L Beitelshees
Lancet (London, England)|April 3, 2012
Personalised antiplatelet treatment: a RAPIDly moving targetAmber L Beitelshees
Heart Failure Reviews|March 21, 2008
Renin-angiotensin-aldosterone system (RAAS) pharmacogenomics: implications in heart failure managementAmber L Beitelshees, Issam Zineh
JAMA|September 22, 2011
Evolving research and stakeholder perspectives on pharmacogenomicsAmber L Beitelshees, David L Veenstra
Trends in Pharmacological Sciences|August 1, 2006
Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safetyAmber L Beitelshees, Howard L McLeod
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 2006
Clopidogrel pharmacogenetics: promising steps towards patient care?Amber L Beitelshees, Howard L McLeod
Interventional Cardiology|August 18, 2023
Familial Hyperlipidemia Caused by Apolipoprotein B Mutation in the Pediatric Amish Population: A Mini ReviewCorey Snyder, Amber L Beitelshees, Devyani Chowdhury
Pharmacogenomics and Personalized Medicine|April 22, 2015
Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomicsAmber L Beitelshees, Deepak Voora, Joshua P Lewis
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 27, 2007
Correlates of serum matrix metalloproteinase-8 (MMP-8) concentrations in nondiabetic subjects without cardiovascular diseaseChristina L Aquilante, Amber L Beitelshees, Issam Zineh
Pharmacogenetics and Genomics|July 19, 2006
Re: Meckley LM, Veenstra DL. Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis. Pharmacogenet Genom 2006; 16:139-147Tobias Gerhard, Amber L Beitelshees, Julie A Johnson
Pageof 13